Popees swap: ₹511 Cr of new paper against a ₹131 Cr market cap leaves current holders ~19% fully diluted
2.60 Cr new shares plus 98.5 lakh warrants at ₹142.44 buy 99.31% of Popees Baby Care Products — ₹511.33 Cr of paper, nearly 4× the listed company's market cap.
₹153.90
Oct 9, 2026 · −5.0% on the filing day
≈ ₹131.2 Cr
0.85 Cr shares × ₹153.90
MICRO-CAP
by market cap ≈ ₹131 Cr
₹511.33 Cr
2.60 Cr shares + 0.99 Cr warrants at ₹142.44
19.2%
24.7% after the equity issue alone
₹131.35–218.55
close is −29.6% from the Apr 20 high
At 00:33 IST on October 9, Popees Baby Care India Limited — the BSE-listed company formerly known as Hari Govind International Ltd. — filed the outcome of a board meeting held the previous evening. The board approved acquiring 99.31% of Popees Baby Care Products Limited (PBCPL), an unlisted baby-products and garments company, paid for entirely in the listed company's own paper: a preferential issue of up to 2,60,44,323 equity shares plus up to 98,53,471 fully convertible warrants, both priced at ₹142.44, for consideration other than cash. Against a company with 85.25 lakh shares outstanding and a market value of roughly ₹131 crore, the filing itself puts the aggregate cost of acquisition at ₹511,32,81,777 — i.e. ₹511.33 crore. The stock closed the session down 5.0%, on 589 traded shares.
A preferential swap bigger than the company issuing it
Board approves 99.31% acquisition of Popees Baby Care Products via preferential share swap
The board, meeting on October 8 from 4:30 PM to 9:30 PM, approved a Share Subscription and Share Purchase Agreement with PBCPL, under which the listed company acquires 99.31% of PBCPL's share capital from its shareholders in a share-swap arrangement. Payment is up to 2,60,44,323 new equity shares (to 199 allottees) and up to 98,53,471 fully convertible warrants (to 83 allottees), both at ₹142.44 — ₹10 face value plus ₹132.44 premium — for consideration other than cash. The board also approved raising authorised capital from ₹10.25 crore to ₹47 crore, fixed October 19, 2026 as the relevant date, and called an EGM for November 18, 2026. The outcome reached the exchange after midnight, pre-open on October 9.
Read:At the issue price the new paper is worth ₹511.33 crore per the filing — against a market cap of about ₹138 crore at the last traded close of ₹162 (Sep 25), before the stock resumed trading. If shareholders approve and the full issue is allotted and converted, today's entire shareholder base would hold about 19.2% of the enlarged company.
BSE filing — board outcome and acquisition disclosure, Oct 9, 2026The mechanics, as the filing states them: the acquisition is a share swap — PBCPL's shareholders hand over their PBCPL shares and receive listed-company shares and warrants in exchange. The warrants convert into equity within 18 months of allotment. The whole arrangement is subject to shareholder approval at the November 18 EGM and to exchange approvals; the filing gives an indicative completion timeline of 15 days from stock exchange approval, and states that no governmental or regulatory approvals are required. The issue price of ₹142.44 was supported by valuation reports from two IBBI-registered valuers, CA Karan C. Shah and CA Bhavesh M. Rathod, and sits about 7.4% below the October 9 close.
Issue price ₹142.44 (₹10 face + ₹132.44 premium); relevant date Oct 19, 2026. Aggregate consideration ₹511.33 Cr per the filing. New authorised capital of ₹47 Cr (4.70 Cr shares) accommodates the enlarged base.
The dilution runs one way, but so does the consolidation of control. The filing's Annexure D shows managing director Shaju Thomas — who signs the filing and holds 47.42% today — receiving 1.38 crore of the new shares (53.1% of the equity issue, listed at ₹196.96 crore) and 73.4 lakh of the warrants (74.5% of them), taking him to 51.69% after the equity issue and 56.75% after warrant conversion. Linta Purayidathil Jose goes from 15.96% to 10.99% fully diluted but with a much larger absolute holding. The filing itself states that post swap, the holdings of the existing promoters of the listed company will be consolidated at 69.63% — versus the 72.15% the promoter group reports today on the far smaller base.
The business of unlisted company becomes the primary business of the Listed company, hence create value addition to stakeholders of listed Company.
— Annexure A, board outcome filing, Oct 9, 2026
The target is several times the size of the acquirer
Target figures as disclosed in Annexure A (turnover of ₹4,581.72 lakh for the June 2026 quarter, i.e. ₹45.82 Cr; FY26 ₹1,61,93,23,627, i.e. ₹161.93 Cr). Full-year figures for the listed company are not in the filings reviewed; its three earlier quarters on record (Q4 FY25, Q1–Q2 FY26) show zero revenue.
The filings disclose PBCPL's turnover but no profit figures for the target — the ₹511 crore of paper is being issued against a top line, with the bottom line undisclosed in these documents. The listed company's own accounts show zero revenue in Q4 FY25 and the first two quarters of FY26, a ₹0.10 crore pre-tax loss in Q2 FY26, and then a first revenue quarter in Q1 FY27: ₹15.73 crore of revenue and ₹0.63 crore of net profit. The two companies share management: the filing's related-party field is answered 'NA', while the same table records that Shaju Thomas and Linta Purayidathil Jose 'are the common promoters in both the management.' PBCPL, incorporated on June 8, 2016, manufactures and trades baby products, garments and fashion apparel across wholesale and retail — the business the filing says will become the listed company's primary one.
Two months from auditor change to swap approval
Q1 FY27 results filed: ₹15.73 Cr revenue, the first revenue quarter on record in two years. The same evening, statutory auditor C.V. Paturkar & Co. resigns (letter dated Aug 6, effective Aug 14, citing pre-occupation with other professional assignments); the board appoints Manikandan & Associates to the casual vacancy.
Board meeting called for Sep 22 to consider raising funds via a preferential issue pursuant to a share-swap arrangement.
Board meets and postpones the swap proposal; the matter is rescheduled to Oct 8.
38th AGM confirms Manikandan & Associates as statutory auditor for a five-year term.
Board meets 4:30–9:30 PM and approves the SSPA, both preferential issues and the authorised-capital increase; the outcome reaches BSE at 00:20–00:33 IST on Oct 9.
Relevant date fixed for pricing the preferential issue.
EGM (by video conference) to vote on the authorised capital increase and both preferential issues.
The tape around all of this is extremely thin. In the last 60 recorded sessions the stock traded no shares at all between July 27 and September 15, and several sessions since cleared exactly one share. Friday's −5.0% reaction — from the prior traded close of ₹162.00 on September 25 to ₹153.90 — came on 589 shares, roughly ₹0.9 lakh of turnover. The adjusted 52-week range runs from ₹131.35 (May 11) to ₹218.55 (April 20); the close sits 29.6% below that high. With promoters at 72.15% and no institutional holders on the register, the free float that actually trades is a sliver — price moves here say less about the market's verdict than they would in a liquid stock.
The gates between approval and allotment
EGM, Nov 18
Shareholders vote on the authorised-capital increase and both preferential issues. With promoters at 72.15%, the arithmetic of the vote favours passage; the resolutions' exact terms are the thing to read.
Exchange approval
The filing's indicative timeline is completion within 15 days of stock exchange approval — the in-principle approval for the preferential issue is the operative external gate.
PBCPL's bottom line
The filings disclose the target's turnover but not its profit. The first consolidated or merged financials will show what ₹511.33 Cr of paper actually bought.
Warrant conversion
98.53 lakh warrants convert within 18 months of allotment — the final step of the dilution, taking the base to 4.44 Cr shares.
Q2 FY27 results
The trading window has been closed since Oct 1 pending the September-quarter results, and reopens 48 hours after they are declared.
What the filing describes is, in substance, the listed company being refitted around its promoters' unlisted business: PBCPL's shareholders receive listed paper, PBCPL's operations become the primary business, and the promoters' stake consolidates at 69.63% on a base five times larger. For the existing public shareholder, the question is not whether dilution happens — at full allotment and conversion it takes today's entire register to about 19.2% — but what stands behind the new shares. The disclosed answer so far is a target with ₹161.93 crore of FY26 turnover and an undisclosed profit line, valued via the swap at ₹511.33 crore for 99.31%.
The near-term calendar is mechanical: the EGM on November 18, exchange approval, allotment within the filing's 15-day indicative window, and warrant conversion inside 18 months. In a stock where days can pass between trades, the filings along that path — the EGM resolutions, the allotment disclosures, and the first financials that consolidate PBCPL — will carry more information than the price.
Informational and educational content only. Not investment advice.